Asmaa Ibrahim
High Inner Centromere Protein Expression Correlates with Aggressive Features and Predicts Poor Prognosis in Patients with Invasive Breast Cancer
Ibrahim, Asmaa; Miligy, Islam M.; Toss, Michael S.; Green, Andrew R.; Rakha, Emad A
Authors
Islam M. Miligy
Michael S. Toss
Dr Andy Green ANDREW.GREEN@NOTTINGHAM.AC.UK
ASSOCIATE PROFESSOR
Professor EMAD RAKHA Emad.Rakha@nottingham.ac.uk
PROFESSOR OF BREAST CANCER PATHOLOGY
Abstract
Introduction: Inner centromere protein (INCENP) is a member of the chromosomal passenger complex (CPC) and plays a key role in mitosis and cell proliferation. This study aims to evaluate the clinical and prognostic significance of INCENP in invasive breast cancer (BC).
Methods: INCENP protein expression was evaluated on a tissue microarray of a large BC cohort (n=1295) using immunohistochemistry. At the mRNA level, INCENP expression was assessed using the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) (n=1980) and Cancer Genome Atlas (TCGA) BC cohorts (n=854). The correlations between INCENP expression, clinicopathological parameters and patient outcome were investigated.
Results: INCENP protein expression was detected in the nucleus and cytoplasm of the tumour cells. Its expression was significantly associated with features characteristic of aggressive BC behaviour including high tumour grade, larger tumour size and high Nottingham Prognostic Index scores. High INCENP nuclear expression was a predictor of shorter BC-specific survival (BCSS) in the whole cohort, as well as in the luminal subtype (p<0.001). High INCENP nuclear expression was predictive of poor prognosis in BC patients who received hormone treatment or chemotherapy.
Conclusion: High INCENP expression is a poor prognostic biomarker in BC with potential therapeutic benefits.
Citation
Ibrahim, A., Miligy, I. M., Toss, M. S., Green, A. R., & Rakha, E. A. (2023). High Inner Centromere Protein Expression Correlates with Aggressive Features and Predicts Poor Prognosis in Patients with Invasive Breast Cancer. Pathobiology, 90(6), 377–388. https://doi.org/10.1159/000529628
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 31, 2023 |
Online Publication Date | Apr 7, 2023 |
Publication Date | 2023-12 |
Deposit Date | Feb 2, 2023 |
Publicly Available Date | Apr 7, 2023 |
Journal | Pathobiology |
Print ISSN | 1015-2008 |
Electronic ISSN | 1423-0291 |
Publisher | Karger Publishers |
Peer Reviewed | Peer Reviewed |
Volume | 90 |
Issue | 6 |
Pages | 377–388 |
DOI | https://doi.org/10.1159/000529628 |
Keywords | Cell Biology, Molecular Biology, General Medicine, Pathology and Forensic Medicine |
Public URL | https://nottingham-repository.worktribe.com/output/16798591 |
Publisher URL | https://www.karger.com/Article/Abstract/529628 |
Files
Main Manuscript (INCENP)
(201 Kb)
PDF
You might also like
The role of the ALKBH5 RNA demethylase in invasive breast cancer
(2024)
Journal Article
Epitranscriptomic mechanisms of androgen signalling and prostate cancer
(2024)
Journal Article
Stromal lymphocytes are associated with upgrade of B3 breast lesions
(2024)
Journal Article
The characteristics and prognostic significance of histone H1 expression in breast cancer
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search